Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes

Cell Transplantation

Volumn 20, Issue 6, 2011, Pages 963-975

  Puppi, Juliana ^a   Mitry, Ragai R ^a   Modo, Michel ^b   Dhawan, Anil ^a   Raja, Kishor ^a   Hughes, Robin D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cell labeling; Contrast agents; Cytotoxicity; Hepatocyte transplantation; Magnetic resonance imaging (MRI); Superapragmagnetic iron oxide nanoparticles (spios)

Indexed keywords

FERROZINE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL FUNCTION; CELL LABELING; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; MICROSCOPY; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; COLORIMETRY; CONTRAST MEDIA; FERRIC COMPOUNDS; HEPATOCYTES; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; SERUM ALBUMIN;

MUS;

EID: 80051773620     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X543367     Document Type: Article

References (42)

1. Arbab A. S.; Bashaw L. A.; Miller B. R.; Jordan E. K.; Lewis B. K.; Kalish H.; Frank J. A. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229:838-846; 2003.
2. Arbab A. S.; Wilson L. B.; Ashari P.; Jordan E. K.; Lewis B. K.; Frank J. A. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: Implications for cellular magnetic resonance imaging. NMR Biomed. 18:383-389; 2005.
3. Berry C. C.; Wells S.; Charles S.; Aitchison G.; Curtis A. S. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials 25:5405-5413; 2004.
4. Bohnen N. I.; Charron M.; Reyes J.; Rubinstein W.; Strom S. C.; Swanson D.; Towbin R. Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin. Nucl. Med. 25:447-450; 2000.
5. Bos C.; Delmas Y.; Desmouliere A.; Solanilla A.; Hauger O.; Grosset C.; Dubus I.; Ivanovic Z.; Rosenbaum J.; Charbord P.; Combe C.; Bulte J. W.; Moonen C. T.; Ripoche J.; Grenier N. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 233:781-789; 2004.
6. Brekke C.; Morgan S. C.; Lowe A. S.; Meade T. J.; Price J.; Williams S. C.; Modo M. The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed. 20:77-89; 2007.
7. Briley-Saebo K.; Bjornerud A.; Grant D.; Ahlstrom H.; Berg T.; Kindberg G. M. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: Implications for magnetic resonance imaging. Cell Tissue Res. 316:315-323; 2004.
8. Bulte J. W.; Kraitchman D. L. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17:484-499; 2004.
9. Dhawan A.; Mitry R. R.; Hughes R. D. Hepatocyte transplantation for liver-based metabolic disorders. J. Inherit. Metab. Dis. 29:431-435; 2006.
10. Donato M. T.; Gomez-Lechon M. J.; Castell J. V. A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatocytes cultured on 96-well plates. Anal. Biochem. 213:29-33; 1993.
11. Ferrini J. B.; Pichard L.; Domergue J.; Maurel P. Long-term primary cultures of adult human hepatocytes. Chem. Biol. Interact. 107:31-45; 1997.
12. Fisher R. A.; Strom S. C. Human hepatocyte transplantation: Worldwide results. Transplantation 82:441-449; 2006.
13. Fu T.; Guo D.; Huang X.; O'Gorman M. R.; Huang L.; Crawford S. E.; Soriano H. E. Apoptosis occurs in isolated and banked primary mouse hepatocytes. Cell Transplant. 10:59-66; 2001.
14. Funaki N.; Tanaka J.; Sugiyama T.; Ohshio G.; Nonaka A.; Yotsumoto F.; Sugie T.; Imamura M. Successive cultures of mature hepatocytes for hepatocyte autotransplantation to assist liver function after liver resection for cancer. Oncol. Rep. 9:713-721; 2002.
15. Guzman R.; Uchida N.; Bliss T. M.; He D.; Christopherson K. K.; Stellwagen D.; Capela A.; Greve J.; Malenka R. C.; Moseley M. E.; Palmer T. D.; Steinberg G. K. Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl. Acad. Sci. USA 104:10211-10216; 2007.
16. Hinds K. A.; Hill J. M.; Shapiro E. M.; Laukkanen M. O.; Silva A. C.; Combs C. A.; Varney T. R.; Balaban R. S.; Koretsky A. P.; Dunbar C. E. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102:867-872; 2003.
17. Horne P. H.; Zimmerer J. M.; Fisher M. G.; Lunsford K. E.; Nadasdy G.; Nadasdy T.; van Rooijen N.; Bumgardner G. L. Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells. J. Immunol. 181:1224-1231; 2008.
18. Hussain S. M.; Hess K. L.; Gearhart J. M.; Geiss K. T.; Schlager J. J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 19:975-983; 2005.
19. Joseph B.; Malhi H.; Bhargava K. K.; Palestro C. J.; McCuskey R. S.; Gupta S. Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology 123:1677-1685; 2002.
20. Kehrer J. P. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149:43-50; 2000.
21. Kostura L.; Kraitchman D. L.; Mackay A. M.; Pittenger M. F.; Bulte J. W. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 17:513-517; 2004.
22. Lowry O. H.; Rosebrough N. J.; Farr A. L.; Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
23. Mas V. R.; Maluf D. G.; Thompson M.; Ferreira-Gonzalez A.; Fisher R. A. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplant. 13:231-236; 2004.
24. Mitry R. R.; Hughes R. D.; Aw M. M.; Terry C.; Mieli-Vergani G.; Girlanda R.; Muiesan P.; Rela M.; Heaton N. D.; Dhawan A. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 12:69-74; 2003.
25. Mitry R. R.; Sarraf C. E.; Havlik R.; Habib N. A. Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment. Hepatology 31:885-889; 2000.
26. Modo M.; Beech J. S.; Meade T. J.; Williams S. C.; Price J. A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 47(Suppl. 2):T133-142; 2009.
27. Modo M.; Hoehn M.; Bulte J. W. Cellular MR imaging. Mol. Imaging 4:143-164; 2005.
28. Muller K.; Skepper J. N.; Posfai M.; Trivedi R.; Howarth S.; Corot C.; Lancelot E.; Thompson P. W.; Brown A. P.; Gillard J. H. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 28:1629-1642; 2007.
29. Nohroudi K.; Arnhold S.; Berhorn T.; Addicks K.; Hoehn M.; Himmelreich U. In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant. 19:431-441; 2010.
30. Papanikolaou G.; Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202:199-211; 2005.
31. Pisanic, 2nd T. R.; Blackwell J. D.; Shubayev V. I.; Finones R. R.; Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 28:2572-2581; 2007.
32. Puppi J.; Modo M. Use of magnetic resonance imaging contrast agents to detect transplanted liver cells. Top. Magn. Reson. Imaging 20:113-120; 2009.
33. Raschzok N.; Morgul M. H.; Pinkernelle J.; Vondran F. W.; Billecke N.; Kammer N. N.; Pless G.; Adonopoulou M. K.; Leist C.; Stelter L.; Teichgraber U.; Schwartlander R.; Sauer I. M. Imaging of primary human hepatocytes performed with micron-sized iron oxide particles and clinical magnetic resonance tomography. J. Cell. Mol. Med. 12:1384-1394; 2008.
34. Riemer J.; Hoepken H. H.; Czerwinska H.; Robinson S. R.; Dringen R. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 331:370-375; 2004.
35. Shapiro E. M.; Sharer K.; Skrtic S.; Koretsky A. P. In vivo detection of single cells by MRI. Magn. Reson. Med. 55:242-249; 2006.
36. Skotland T.; Sontum P. C.; Oulie I. In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. J. Pharm. Biomed. Anal. 28:323-329; 2002.
37. So P. W.; Kalber T.; Hunt D.; Farquharson M.; Al-Ebraheem A.; Parkes H. G.; Simon R.; Bell J. D. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxide nanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI. Cell Transplant. 19:419-429; 2010.
38. Stephenne X.; Najimi M.; Sibille C.; Nassogne M. C.; Smets F.; Sokal E. M. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130:1317-1323; 2006.
39. Stephenne X.; Vosters O.; Najimi M.; Beuneu C.; Dung K. N.; Wijns W.; Goldman M.; Sokal E. M. Tissue factor-dependent procoagulant activity of isolated human hepatocytes: Relevance to liver cell transplantation. Liver Transpl. 13:599-606; 2007.
40. Wang L. J.; Chen Y. M.; George D.; Smets F.; Sokal E. M.; Bremer E. G.; Soriano H. E. Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences. Liver Transpl. 8:822-828; 2002.
41. Wang Y. X.; Hussain S. M.; Krestin G. P. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11:2319-2331; 2001.
42. Weissleder R.; Stark D. D.; Engelstad B. L.; Bacon B. R.; Compton C. C.; White D. L.; Jacobs P.; Lewis J. Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152:167-173; 1989.